A UNIQUE IMMUNOPHENOTYPE (IP) DEFINES CASES OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITH CHROMOSOME-11Q23 ABNORMALITIES AND POOR OUTCOME - A PEDIATRIC ONCOLOGY GROUP (POG) STUDY

被引:0
|
作者
BOROWITZ, MJ
CARROLL, AJ
SHUSTER, JJ
BEHM, FG
PULLEN, DJ
FRANKEL, L
CRIST, WM
LAND, V
机构
[1] DUKE UNIV,DURHAM,NC 27706
[2] POG,ST LOUIS,MO
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A68 / A68
页数:1
相关论文
共 50 条
  • [41] E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias (ALLs) with A t(1;19)(q23;p13): A pediatric oncology group (POG) study.
    Hunger, SP
    Fall, MZ
    Camitta, BM
    Carroll, AJ
    Link, MP
    Lauer, SJ
    Mahoney, DH
    Pullen, DJ
    Shuster, JJ
    Steuber, CP
    Cleary, ML
    BLOOD, 1997, 90 (10) : 1880 - 1880
  • [42] TENIPOSIDE (VM-26) AND CONTINUOUS INFUSION CYTOSINE-ARABINOSIDE FOR INITIAL INDUCTION FAILURE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP PILOT-STUDY
    OCHS, J
    RIVERA, GK
    POLLOCK, BH
    BUCHANAN, G
    CRIST, W
    FREEMAN, AI
    CANCER, 1990, 66 (08) : 1671 - 1677
  • [43] Consolidation therapy with intermediate dose methotrexate (IDM) alone, or IDM and L-asparaginase (ASP), or IDM and cytosine arabinoside (ARAC) in standard risk acute lymphoblastic leukemia (ALL) of childhood: A pediatric oncology group (POG) study.
    Harris, MB
    Land, VJ
    Shuster, JJ
    Borowitz, MJ
    Behm, FG
    Pullen, DJ
    BLOOD, 1996, 88 (10) : 2661 - 2661
  • [44] PHENOTYPES ENCOUNTERED IN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) DO NOT REFLECT STAGES OF NORMAL B-CELL DIFFERENTIATION - A PEDIATRIC ONCOLOGY GROUP-STUDY
    BOROWITZ, MJ
    CIVIN, CI
    BEHM, FG
    FALLETTA, JM
    SHUSTER, J
    HURWITZ, CA
    CARROLL, AJ
    LOOK, T
    PULLEN, DJ
    CRIST, WM
    MODERN PATHOLOGY, 1988, 1 (01) : A11 - A11
  • [45] PHENOTYPES ENCOUNTERED IN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) DO NOT REFLECT STAGES OF NORMAL B-CELL DIFFERENTIATION, A PEDIATRIC ONCOLOGY GROUP-STUDY
    BOROWITZ, MJ
    CIVIN, CI
    BEHM, FG
    FALLETTA, JM
    SHUSTER, J
    HURWITZ, CA
    CARROLL, AJ
    LOOK, T
    PULLEN, DJ
    CRIST, WM
    LABORATORY INVESTIGATION, 1988, 58 (01) : A11 - A11
  • [46] INTRAVENOUS IMMUNOGLOBULIN MAY LESSEN ALL FORMS OF INFECTION IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
    GRAHAMPOLE, J
    CAMITTA, B
    CASPER, J
    ELFENBEIN, G
    GROSS, S
    HERZIG, R
    KOCH, P
    MAHONEY, D
    MARCUS, R
    MUNOZ, L
    PICK, T
    SPRUCE, W
    STEUBER, P
    WEINER, R
    BONE MARROW TRANSPLANTATION, 1988, 3 (06) : 559 - 566
  • [47] CYTOGENETIC FEATURES OF INFANTS LESS-THAN 12 MONTHS OF AGE AT DIAGNOSIS OF ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPACT OF THE 11Q23 BREAKPOINT ON OUTCOME - A REPORT OF THE CHILDRENS CANCER GROUP
    HEEREMA, NA
    ARTHUR, DC
    SATHER, H
    ALBO, V
    FEUSNER, J
    LANGE, BJ
    STEINHERZ, PG
    ZELTZER, P
    HAMMOND, D
    REAMAN, GH
    BLOOD, 1994, 83 (08) : 2274 - 2284
  • [48] BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - IMPACT OF CONDITIONING WITH CYTOSINE-ARABINOSIDE (ARAC) AND FRACTIONATED TOTAL-BODY IRRADIATION (FTBI) ON SUBSEQUENT RELAPSE (REL) - A PEDIATRIC ONCOLOGY GROUP (POG) PILOTI
    GRAHAMPOLE, J
    GROSS, S
    CAMITTA, B
    CASPER, J
    HERZIG, R
    NORRIS, D
    KOCH, P
    STEUBER, P
    BOYETT, J
    MARCUS, R
    MUNOZ, L
    ELFENBEIN, G
    WEINER, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 206 - 206
  • [49] COMPARISON OF 2 SCHEDULES OF INTERMEDIATE-DOSE METHOTREXATE AND CYTARABINE CONSOLIDATION THERAPY FOR CHILDHOOD B-PRECURSOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    LAND, VJ
    SHUSTER, JJ
    CRIST, WM
    RAVINDRANATH, Y
    HARRIS, MB
    KRANCE, RA
    PINKEL, D
    PULLEN, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) : 1939 - 1945
  • [50] Ataxia telangiectasia gene (ATM) alterations in childhood precursor B (precursor B-ALL) and T (T-ALL) acute lymphoblastic leukemias detected by DHPLC (denaturating high performance liquid chromatography). a collaborative study between the Swiss Pediatric Oncology Group (SPOG) and the Pediatric Oncology Group (POG).
    Pause, FG
    Wacker, P
    Maillet, P
    Betts, D
    Sappino, AP
    BLOOD, 2001, 98 (11) : 167B - 167B